Alamance Cancer Center at Alamance Regional Medical Center

Burlington, North Carolina 27216

0 studies enrolling now · 17 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Fallopian Tube Cancer, Fatigue, Head and Neck Cancer, Hot Flashes, Lung Cancer, Metastatic Cancer, Ovarian Cancer, Precancerous Condition

Studies at this site

• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer — Completed
• Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer — Status unconfirmed
• Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery — Stopped early
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer — Completed
• High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery — Completed
• Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer — Completed
• S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy — Completed
• Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer — Completed
• St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer — Stopped early
• Soy Protein/Effexor Hormone Therapy for Prostate Cancer — Stopped early
• Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer — Completed
• L-Arginine Supplements in Treating Women Who Are Cancer Survivors — Completed
• Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer — Completed
• Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer — Completed
• Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery — Status unconfirmed
• Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer — Completed
• Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer — Completed